News
2021-09-24 13:45
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED KINGDOM, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH...
2021-09-07 09:25
iZafe Group AB (publ.) announces that their pilot project with consumers now has been completed with a positive result, which paves the way for a successful launch in the Swedish and Italian markets. The test participators in the pilot project have had...
2021-09-06 15:15
iZafe Group AB (publ.) announces the opportunity for shareholders, media, and other stakeholders to ask company-related questions in connection with the publication of the Rights Issue which was communicated by press release today, September 6, 2021...
2021-09-06 08:30
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED KINGDOM, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH...
2021-08-31 08:30
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management has signed an exclusive collaboration agreement with Apoteket AB to introduce the medication...
2021-07-19 12:52
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related...
2021-07-15 09:45
Erik Gillsbro began his employment at iZafe Group as product owner for Dosell in April 2021. He has had an intensive learning period and has already been maximally involved in the upcoming launch of Dosell Consumer, the development of Dosell 2.0 and the...
2021-07-14 12:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management - updates the market about the pilot project that is now being carried out with consumers to...
2021-06-14 09:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management announces that it has signed a letter of intent with Apoteket AB to investigate the possibilities...
2021-06-10 10:45
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management announces that it is launching a pilot project with twenty selected people from a group of several...
2021-06-09 14:50
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management decided in November 2018 on a warrant program, TO 6 B. The exercise period for the warrants of...
2021-06-08 09:45
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management announces today that the company's pharmaceutical robot Dosell has been registered in the...
2021-05-03 12:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management updates the market on the latest developments of the next generation of Dosell - Dosell 2.0 which...
2021-04-29 08:30
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - today April 29, releases its Q1 Interim Report 2021. Read the full report here. Summary of financial performance Important events in the quarter Important events since the...
2021-04-26 10:00
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related...
2021-04-21 10:50
iZafe Group AB (publ) (“iZafe Group” or “the Company”) issued 1,000,000 warrants (TO9) in connection with the procurement of a credit facility during April 2020. The exercise period for the TO 9 series warrants began on 12 April...
2021-03-04 11:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management – announces that it has completed a pilot project with the healthcare company TioHundra...
2021-02-25 11:00
Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - a leading Life-Science company in healthcare digitalization announces that the company's major shareholders have appointed a nomination committee. iZafe Group AB's major...
2021-02-24 16:45
Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - a leading Life-Science company in healthcare digitalization announces an expansion of its information provided to shareholders and other stakeholders. As a complement to the communication...
2021-02-19 08:30
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - today February 19, releases its year-end report of the forth quarter 2020. Read the full report here. Condensed statement of financial performance Significant events during...
2021-02-18 15:30
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B), a leading Life Science company focused on the digitalisation of healthcare, is announcing that the board of directors of iZafe Group AB (“iZafe” or “the company”)...